K.W. Wood, C. Sarnecki, T.M. Roberts, J. Blenis, "ras mediates nerve growth factor receptor modulation of three signal- transducing protein kinases: MAP kinase, Raf-1 ...
13don MSN
Elironrasib may overcome resistance to prior KRAS G12C inhibition in non-small cell lung cancer
Elironrasib led to meaningful and durable responses in patients with metastatic KRAS G12C-mutated non-small cell lung cancer ...
Mantle Cell Lymphoma: Optimal Treatment With Bruton Tyrosine Kinase–Targeted Approaches. If you have the appropriate software installed, you can download article citation data to the citation manager ...
The treatment landscape for advanced hepatocellular carcinoma has changed dramatically over the past 4 years. We now have numerous options for patients in frontline, second-line, and beyond. The most ...
Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study suggests. The findings of a clinical trial led by the ...
HONG KONG & SUZHOU, China & SHANGHAI--(BUSINESS WIRE)--Zion Pharma Limited, a Chinese biotechnology company focused on the development of brain-penetrable compounds, today announced that Roche has ...
S.M. Thomas, M. DeMarco, G. D'Arcangelo, S. Halegoua, J.S. Brugge, "Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback